Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
Precious Idogun, Mindy Ward, Yeshanew Teklie, Wilhelmine Wiese‐Rometsch, Joel Baker
Abstract
A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-year-old Caucasian female who presented to the emergency room with life-threatening thrombocytopenia in the setting of de novo ITP following COVID-19 vaccine administration. Due to the relapsing nature of ITP, it is unclear if the patient has achieved complete remission of the disease.
Topics & Concepts
MedicineImmune thrombocytopeniaCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Disease2019-20 coronavirus outbreakPediatricsAdministration (probate law)ImmunologyInternal medicineVirologyInfectious disease (medical specialty)PlateletOutbreakPolitical scienceLawPlatelet Disorders and TreatmentsHeparin-Induced Thrombocytopenia and ThrombosisBlood groups and transfusion